ArticleCureus2026
Giant Uterine Leiomyoma With Concomitant Occult Ovarian Carcinoma: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Uterine leiomyomas are common benign tumors, whereas "giant" leiomyomas occupying most of the abdominal cavity are now uncommon and can pose diagnostic and operative challenges. We present the case of a 45-year-old woman with progressive abdominal distension and long-standing menorrhagia. Computed tomography demonstrated a massive uterine fundal mass consistent with a giant subserosal leiomyoma and a separate right adnexal cystic lesion. The patient underwent elective midline laparotomy and total abdominal hysterectomy with bilateral salpingo-oophorectomy. The ovarian cyst was removed intact without capsular rupture, and peritoneal washings were obtained. Estimated blood loss was 80 mL. Postoperative recovery followed an enhanced recovery after surgery (ERAS) pathway, enabling discharge on postoperative day four. Final histopathology confirmed a giant subserosal leiomyoma measuring 44 × 38 × 30 cm and revealed an occult clear cell carcinoma confined to the ovarian cyst (FIGO stage IA), with negative peritoneal cytology. Completion staging surgery and adjuvant-treatment discussion were recommended at a multidisciplinary tumor board; however, the patient declined further extensive surgery and was referred to medical oncology for adjuvant management and close surveillance. This case highlights the complexity of removal in giant uterine tumors, careful handling of adnexal cysts to avoid intraoperative rupture, and the feasibility of ERAS-based recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.